BRITTANY HARTMAN: Open Payments
NPI 1528494911 · COLDWATER, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,159 in 62 payments from 17 companies in 2025. Trend: 2023 $1,023 · 2024 $901 · 2025 $1,159
Food & beverage: $1,159
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $231 |
| ABBVIE INC. | 7 | $193 |
| Otsuka America Pharmaceutical, Inc. | 11 | $189 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $92 |
| VERTEX PHARMACEUTICALS INCORPORATED | 5 | $80 |
| Novo Nordisk Inc | 3 | $55 |
| Endo USA, Inc. | 3 | $44 |
| Abbott Laboratories | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
Products named: REXULTI, AIRSUPRA, QULIPTA, Kerendia, JOURNAVX, VRAYLAR, FARXIGA, Wegovy.
Industry payments across MI — which companies pay providers there.
